Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Cash from Investing Activities: 2010-2017

Historic Cash from Investing Activities for Tenax Therapeutics (TENX) over the last 7 years, with Dec 2017 value amounting to $1.1 million.

  • Tenax Therapeutics' Cash from Investing Activities fell 90.93% to $1.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was $3.7 million, marking a year-over-year decrease of 83.12%. This contributed to the annual value of $3,000 for FY2023, which is 229.14% up from last year.
  • As of Q4 2017, Tenax Therapeutics' Cash from Investing Activities stood at $1.1 million, which was up 48.52% from $756,129 recorded in Q3 2017.
  • Over the past 5 years, Tenax Therapeutics' Cash from Investing Activities peaked at $12.4 million during Q4 2016, and registered a low of -$34.6 million during Q3 2014.
  • For the 3-year period, Tenax Therapeutics' Cash from Investing Activities averaged around $2.2 million, with its median value being $1.1 million (2017).
  • In the last 5 years, Tenax Therapeutics' Cash from Investing Activities tumbled by 104,185.66% in 2014 and then surged by 98.90% in 2015.
  • Over the past 5 years, Tenax Therapeutics' Cash from Investing Activities (Quarterly) stood at -$3.7 million in 2013, then fell by 25.07% to -$4.7 million in 2014, then surged by 98.90% to -$380,876 in 2015, then reached $12.4 million in 2016, then crashed by 90.93% to $1.1 million in 2017.
  • Its Cash from Investing Activities stands at $1.1 million for Q4 2017, versus $756,129 for Q3 2017 and $800,501 for Q2 2017.